SkinBioTherapeutics (GB:SBTX) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
In a significant update from SkinBioTherapeutics PLC, David Campbell Brierwood has crossed a threshold in voting rights, now holding 3.1% of the company with 6,998,305 total voting rights as of August 12, 2024. This change in shareholding structure was formally notified to the company on the following day. No voting rights are held through financial instruments, indicating a straightforward equity stake.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
